Cite
HARVARD Citation
Rong, D. et al. (2023). GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. Journal for immunotherapy of cancer. 11 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rong, D. et al. (2023). GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. Journal for immunotherapy of cancer. 11 (2), p. . [Online].